A detailed history of Swiss National Bank transactions in Boston Scientific Corp stock. As of the latest transaction made, Swiss National Bank holds 4,363,600 shares of BSX stock, worth $388 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
4,363,600
Previous 4,352,000 0.27%
Holding current value
$388 Million
Previous $335 Million 9.11%
% of portfolio
0.24%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$72.96 - $84.0 $846,335 - $974,400
11,600 Added 0.27%
4,363,600 $366 Million
Q2 2024

Aug 08, 2024

SELL
$67.33 - $77.71 $2.37 Million - $2.74 Million
-35,200 Reduced 0.8%
4,352,000 $335 Million
Q1 2024

May 07, 2024

SELL
$57.6 - $68.62 $11 Million - $13.1 Million
-191,500 Reduced 4.18%
4,387,200 $300 Million
Q4 2023

Feb 06, 2024

SELL
$48.64 - $57.81 $2.22 Million - $2.64 Million
-45,600 Reduced 0.99%
4,578,700 $265 Million
Q3 2023

Nov 08, 2023

SELL
$50.19 - $54.68 $28.4 Million - $31 Million
-566,800 Reduced 10.92%
4,624,300 $244 Million
Q2 2023

Aug 09, 2023

SELL
$49.72 - $54.64 $24.5 Million - $26.9 Million
-493,200 Reduced 8.68%
5,191,100 $281 Million
Q1 2023

May 10, 2023

SELL
$45.09 - $50.03 $6.05 Million - $6.71 Million
-134,100 Reduced 2.3%
5,684,300 $284 Million
Q4 2022

Feb 08, 2023

SELL
$39.56 - $47.22 $14.9 Million - $17.8 Million
-376,980 Reduced 6.08%
5,818,400 $269 Million
Q3 2022

Nov 09, 2022

BUY
$36.71 - $109.66 $238,615 - $712,790
6,500 Added 0.11%
6,195,380 $240 Million
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $595,556 - $795,990
16,900 Added 0.27%
6,188,880 $231 Million
Q1 2022

May 09, 2022

BUY
$40.9 - $45.1 $31.1 Million - $34.3 Million
760,000 Added 14.04%
6,171,980 $273 Million
Q4 2021

Feb 08, 2022

SELL
$38.07 - $44.87 $8.04 Million - $9.47 Million
-211,100 Reduced 3.75%
5,411,980 $230 Million
Q3 2021

Nov 08, 2021

SELL
$41.23 - $45.88 $6.41 Million - $7.13 Million
-155,500 Reduced 2.69%
5,623,080 $244 Million
Q2 2021

Aug 06, 2021

BUY
$38.58 - $44.24 $1.91 Million - $2.19 Million
49,555 Added 0.86%
5,778,580 $247 Million
Q1 2021

May 07, 2021

BUY
$35.27 - $39.67 $3.77 Million - $4.24 Million
106,800 Added 1.9%
5,729,025 $221 Million
Q4 2020

Feb 05, 2021

SELL
$33.15 - $41.97 $4.81 Million - $6.09 Million
-145,000 Reduced 2.51%
5,622,225 $202 Million
Q3 2020

Nov 09, 2020

BUY
$34.44 - $42.23 $1.35 Million - $1.66 Million
39,300 Added 0.69%
5,767,225 $220 Million
Q2 2020

Aug 05, 2020

BUY
$30.19 - $39.11 $3.25 Million - $4.21 Million
107,600 Added 1.91%
5,727,925 $201 Million
Q1 2020

May 08, 2020

BUY
$25.83 - $45.71 $26.9 Million - $47.7 Million
1,042,500 Added 22.77%
5,620,325 $183 Million
Q4 2019

Feb 06, 2020

SELL
$37.87 - $45.37 $17.1 Million - $20.5 Million
-452,700 Reduced 9.0%
4,577,825 $207 Million
Q3 2019

Nov 12, 2019

SELL
$40.31 - $43.45 $1.48 Million - $1.6 Million
-36,805 Reduced 0.73%
5,030,525 $205 Million
Q2 2019

Aug 02, 2019

SELL
$34.91 - $42.98 $4.52 Million - $5.56 Million
-129,400 Reduced 2.49%
5,067,330 $218 Million
Q1 2019

May 10, 2019

BUY
$32.91 - $40.75 $375,173 - $464,550
11,400 Added 0.22%
5,196,730 $199 Million
Q4 2018

Feb 13, 2019

BUY
$31.73 - $39.04 $2.41 Million - $2.97 Million
76,000 Added 1.49%
5,185,330 $183 Million
Q3 2018

Nov 08, 2018

SELL
$32.83 - $38.63 $5.25 Million - $6.18 Million
-159,900 Reduced 3.03%
5,109,330 $197 Million
Q2 2018

Aug 09, 2018

BUY
$26.84 - $34.32 $3.82 Million - $4.88 Million
142,200 Added 2.77%
5,269,230 $172 Million
Q1 2018

May 04, 2018

SELL
$25.2 - $28.54 $14.2 Million - $16.1 Million
-562,900 Reduced 9.89%
5,127,030 $140 Million
Q4 2017

Feb 07, 2018

BUY
$24.79 - $29.8 $773,448 - $929,760
31,200 Added 0.55%
5,689,930 $141 Million
Q3 2017

Nov 03, 2017

BUY
$26.26 - $29.17 $149 Million - $165 Million
5,658,730
5,658,730 $165 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.